PerkinElmer Vectra 3 Multiplex Biomarker Imaging System

Friday, 01 April, 2016 | Supplied by: PerkinElmer Pty Ltd


Standard IHC methods provide essential clinical data but provide limited information in both the research and clinical setting. The ability to detect, measure, visualise and compare multiple cell phenotypes and cell populations (eg, immune cells, cancer cells, etc) simultaneously in a single FFPE tissue section or TMA is now becoming a critical requirement both for researchers and clinicians.

The Vectra 3 automated quantitative pathology imaging system detects and measures multiple overlapping biomarkers within a single H&E, IHC or IF intact FFPE tissue section or TMA. In combination with PerkinElmer’s range of Opal multiplex staining and amplification tools, the ability to visualise, measure and compare numerous cell phenotypes on a single FFPE tissues section or TMA is now a routine and robust workflow.

The automated quantitative pathology imaging system is available as a 6-slide or 200-slide configuration. Vectra 3 and inForm software analysis, including Phenochart, combine the power of multiplexed biomarker imaging, annotation capability and quantitative analysis within a familiar digital pathology workflow. In combination with Spotfire for Quantitative Pathology, the ability to mine data in an easy-to-use visual environment will accelerate research with a real potential to influence clinical treatment options.

For more information: http://www.perkinelmer.com/product/vectra-3-0-200-slide-cls142338.

Online: www.perkinelmer.com
Phone: 1800 033 391
Related Products

JEOL JSM-IT510 series scanning electron microscope

Scanning electron microscope (SEM) applications are expanding to include not only basic research,...

Thermo Scientific Orbitrap Exploris MX mass spectrometer

The Thermo Scientific Orbitrap Exploris MX mass detector allows biopharmaceutical laboratories to...

JEOL ECZ Luminous (JNM-ECZL series) nuclear magnetic resonance spectrometers

The series is designed to offer spectrometer miniaturisation and extended performance through...


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd